|
Name |
1,4-Benzenediol, 2-(3-methyl-3-buten-1-ynyl)-
|
Molecular Formula | C11H10O2 | |
IUPAC Name* |
2-(3-methylbut-3-en-1-ynyl)benzene-1,4-diol
|
|
SMILES |
CC(=C)C#CC1=C(C=CC(=C1)O)O
|
|
InChI |
InChI=1S/C11H10O2/c1-8(2)3-4-9-7-10(12)5-6-11(9)13/h5-7,12-13H,1H2,2H3
|
|
InChIKey |
ZUEGEPDZNAILQJ-UHFFFAOYSA-N
|
|
Synonyms |
Siccayne; 22944-03-2; 1,4-Benzenediol, 2-(3-methyl-3-buten-1-ynyl)-; 2-(3-methylbut-3-en-1-yn-1-yl)benzene-1,4-diol; 2-(3-methylbut-3-en-1-ynyl)benzene-1,4-diol; 1,4-Benzenediol, 2-(3-methyl-3-buten-1-yn-1-yl)-; starbld0000844; 4-(2,4-Dihydroxyphenyl)-2-methyl-1-buten-3-yne; CHEMBL455767; SCHEMBL7743606; DTXSID00945629; CHEBI:156304
|
|
CAS | 22944-03-2 | |
PubChem CID | 189063 | |
ChEMBL ID | CHEMBL455767 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 174.2 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.469 |
Caco-2 Permeability: | -4.564 | MDCK Permeability: | 0.00002000 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.656 |
30% Bioavailability (F30%): | 0.045 |
Blood-Brain-Barrier Penetration (BBB): | 0.585 | Plasma Protein Binding (PPB): | 83.21% |
Volume Distribution (VD): | 0.463 | Fu: | 5.54% |
CYP1A2-inhibitor: | 0.873 | CYP1A2-substrate: | 0.809 |
CYP2C19-inhibitor: | 0.738 | CYP2C19-substrate: | 0.169 |
CYP2C9-inhibitor: | 0.734 | CYP2C9-substrate: | 0.942 |
CYP2D6-inhibitor: | 0.505 | CYP2D6-substrate: | 0.868 |
CYP3A4-inhibitor: | 0.73 | CYP3A4-substrate: | 0.241 |
Clearance (CL): | 14.685 | Half-life (T1/2): | 0.796 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.017 |
Drug-inuced Liver Injury (DILI): | 0.842 | AMES Toxicity: | 0.452 |
Rat Oral Acute Toxicity: | 0.908 | Maximum Recommended Daily Dose: | 0.896 |
Skin Sensitization: | 0.951 | Carcinogencity: | 0.703 |
Eye Corrosion: | 0.987 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.951 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004655 | 0.698 | D0YF3X | 0.317 | ||||
ENC005851 | 0.667 | D0C4YC | 0.306 | ||||
ENC000344 | 0.488 | D0T7OW | 0.300 | ||||
ENC004656 | 0.462 | D0BA6T | 0.298 | ||||
ENC003699 | 0.446 | D04PHC | 0.296 | ||||
ENC004654 | 0.431 | D0V9EN | 0.296 | ||||
ENC000097 | 0.422 | D03UOT | 0.295 | ||||
ENC000696 | 0.409 | D0U0OT | 0.293 | ||||
ENC000985 | 0.409 | D07MOX | 0.288 | ||||
ENC000500 | 0.404 | D08HVR | 0.286 |